Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 2
1974 2
1975 12
1976 18
1977 24
1978 22
1979 33
1980 16
1981 31
1982 32
1983 41
1984 34
1985 32
1986 134
1987 283
1988 319
1989 352
1990 398
1991 413
1992 452
1993 543
1994 474
1995 713
1996 867
1997 885
1998 975
1999 977
2000 1046
2001 1269
2002 1339
2003 1263
2004 1354
2005 1574
2006 1443
2007 1409
2008 1323
2009 1372
2010 1329
2011 1360
2012 1384
2013 1473
2014 1353
2015 1390
2016 1187
2017 1124
2018 1192
2019 1101
2020 957
2021 629
2022 184
2023 118
2024 65

Text availability

Article attribute

Article type

Publication date

Search Results

33,430 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis.
da Costa BR, Pereira TV, Saadat P, Rudnicki M, Iskander SM, Bodmer NS, Bobos P, Gao L, Kiyomoto HD, Montezuma T, Almeida MO, Cheng PS, Hincapié CA, Hari R, Sutton AJ, Tugwell P, Hawker GA, Jüni P. da Costa BR, et al. BMJ. 2021 Oct 12;375:n2321. doi: 10.1136/bmj.n2321. BMJ. 2021. PMID: 34642179 Free PMC article.
Comparison of intravenous paracetamol (acetaminophen) to intravenously or intramuscularly administered non-steroidal anti-inflammatory drugs (NSAIDs) or opioids for patients presenting with moderate to severe acute pain conditions to the ED: systematic review and meta-analysis.
Qureshi I, Abdulrashid K, Thomas SH, Abdel-Rahman ME, Pathan SA, Harris T. Qureshi I, et al. Emerg Med J. 2023 Jul;40(7):499-508. doi: 10.1136/emermed-2022-212869. Epub 2023 May 12. Emerg Med J. 2023. PMID: 37173122
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. D'Haens G, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.
33,430 results
You have reached the last available page of results. Please see the User Guide for more information.